These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28277138)

  • 41. Role of vitamin E and D
    Fatemi F; Mohammadzadeh A; Sadeghi MR; Akhondi MM; Mohammadmoradi S; Kamali K; Lackpour N; Jouhari S; Zafadoust S; Mokhtar S; Giahi L
    Clin Nutr ESPEN; 2017 Apr; 18():23-30. PubMed ID: 29132734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of calorie-restriction along with thylakoid membranes of spinach on the gut-brain Axis Pathway and oxidative stress biomarkers in obese women with polycystic ovary syndrome: a Randomized, Double-blind, placebo-controlled clinical trial.
    Nikrad N; Farhangi MA; Fard Tabrizi FP; Vaezi M; Mahmoudpour A; Mesgari-Abbasi M
    J Ovarian Res; 2023 Nov; 16(1):216. PubMed ID: 37968684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study.
    Zhao JF; Li BX; Zhang Q
    Ann Palliat Med; 2021 Jan; 10(1):169-183. PubMed ID: 33545754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial.
    Sangouni AA; Sasanfar B; Ghadiri-Anari A; Hosseinzadeh M
    Clin Nutr ESPEN; 2021 Dec; 46():54-59. PubMed ID: 34857248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome.
    El Sharkwy IA; Abd El Aziz WM
    Int J Gynaecol Obstet; 2019 Oct; 147(1):59-64. PubMed ID: 31273783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
    Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of inulin-type fructans with different degrees of polymerization on inflammation, oxidative stress and endothelial dysfunction in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Ziaei R; Shahshahan Z; Ghasemi-Tehrani H; Heidari Z; Ghiasvand R
    Clin Endocrinol (Oxf); 2022 Sep; 97(3):319-330. PubMed ID: 35261049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ostadmohammadi V; Soleimani A; Bahmani F; Aghadavod E; Ramezani R; Reiter RJ; Mansournia MA; Banikazemi Z; Soleimani M; Zaroudi M; Asemi Z
    J Ren Nutr; 2020 May; 30(3):242-250. PubMed ID: 31597622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome.
    Sadeghi F; Alavi-Naeini A; Mardanian F; Ghazvini MR; Mahaki B
    Int J Vitam Nutr Res; 2020 Oct; 90(5-6):477-483. PubMed ID: 30961460
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akbari M; Ostadmohammadi V; Lankarani KB; Tabrizi R; Kolahdooz F; Heydari ST; Kavari SH; Mirhosseini N; Mafi A; Dastorani M; Asemi Z
    Horm Metab Res; 2018 Apr; 50(4):271-279. PubMed ID: 29475212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Zadeh Modarres S; Heidar Z; Foroozanfard F; Rahmati Z; Aghadavod E; Asemi Z
    Biol Trace Elem Res; 2018 Jun; 183(2):218-225. PubMed ID: 28875327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial.
    Ismail AM; Hamed AH; Saso S; Thabet HH
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():148-52. PubMed ID: 25015747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome.
    Sathyapalan T; Shepherd J; Coady AM; Kilpatrick ES; Atkin SL
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3951-5. PubMed ID: 22879630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Ahmadi S; Jamilian M; Karamali M; Tajabadi-Ebrahimi M; Jafari P; Taghizadeh M; Memarzadeh MR; Asemi Z
    Hum Fertil (Camb); 2017 Dec; 20(4):254-261. PubMed ID: 28142296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z
    Ann Nutr Metab; 2015; 67(1):42-8. PubMed ID: 26279073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome.
    Farsinejad-Marj M; Azadbakht L; Mardanian F; Saneei P; Esmaillzadeh A
    Biol Trace Elem Res; 2020 Aug; 196(2):349-358. PubMed ID: 31960275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.